Raras
Buscar doenças, sintomas, genes...
Síndrome de deleção 1p36
ORPHA:1606CID-10 · Q93.5CID-11 · LD44.11OMIM 607872DOENÇA RARA

Anomalia cromossômica caracterizada por características dismórficas faciais distintas, hipotonia, atraso no desenvolvimento, deficiência intelectual, convulsões, defeitos cardíacos, deficiência auditiva e deficiência de crescimento de início pré-natal.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Anomalia cromossômica caracterizada por características dismórficas faciais distintas, hipotonia, atraso no desenvolvimento, deficiência intelectual, convulsões, defeitos cardíacos, deficiência auditiva e deficiência de crescimento de início pré-natal.

Pesquisas ativas
1 ensaio
2 total registrados no ClinicalTrials.gov
Publicações científicas
136 artigos
Último publicado: 2026 Apr 1

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
15.0
United States
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q93.5
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
19 sintomas
🧠
Neurológico
15 sintomas
😀
Face
14 sintomas
❤️
Coração
13 sintomas
👁️
Olhos
11 sintomas
🫃
Digestivo
9 sintomas

+ 51 sintomas em outras categorias

Características mais comuns

100%prev.
Sobrancelha horizontal
Muito frequente (99-80%)
100%prev.
Filtro longo
Muito frequente (99-80%)
100%prev.
Retrusão médio-facial
Muito frequente (99-80%)
100%prev.
Ponte nasal ampla
Muito frequente (99-80%)
100%prev.
Atraso global do desenvolvimento
Muito frequente (99-80%)
95%prev.
Hipotonia neonatal
Frequência: 57/60
156sintomas
Muito frequente (26)
Frequente (31)
Ocasional (60)
Muito raro (1)
Sem dados (38)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 156 características clínicas mais associadas, ordenadas por frequência.

Sobrancelha horizontalHorizontal eyebrow
Muito frequente (99-80%)100%
Filtro longoLong philtrum
Muito frequente (99-80%)100%
Retrusão médio-facialMidface retrusion
Muito frequente (99-80%)100%
Ponte nasal amplaWide nasal bridge
Muito frequente (99-80%)100%
Atraso global do desenvolvimentoGlobal developmental delay
Muito frequente (99-80%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico136PubMed
Últimos 10 anos63publicações
Pico20219 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.

LUZP1Leucine zipper protein 1Role in the phenotype ofAltamente restrito
FUNÇÃO

F-actin cross-linking protein (PubMed:30990684). Stabilizes actin and acts as a negative regulator of primary cilium formation (PubMed:32496561). Positively regulates the phosphorylation of both myosin II and protein phosphatase 1 regulatory subunit PPP1R12A/MYPT1 and promotes the assembly of myosin II stacks within actin stress fibers (PubMed:38832964). Inhibits the phosphorylation of myosin light chain MYL9 by DAPK3 and suppresses the constriction velocity of the contractile ring during cytoki

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal bodyMidbodyChromosome, centromereCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, stress fiberNucleusCell projection, dendritePerikaryonCell junction, tight junction

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
25.6 TPM
Testículo
21.6 TPM
Pulmão
18.0 TPM
Brain Frontal Cortex BA9
17.4 TPM
Córtex cerebral
16.9 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:14985UniProt:Q86V48
CASZ1Zinc finger protein castor homolog 1Role in the phenotype ofAltamente restrito
FUNÇÃO

Transcriptional activator (PubMed:23639441, PubMed:27693370). Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 (PubMed:23639441)

LOCALIZAÇÃO

Nucleus

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:26002UniProt:Q86V15
SKISki oncogeneRole in the phenotype ofRestrito
FUNÇÃO

May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Downregulation of SMAD2/3:SMAD4 transcriptional activitySignaling by BMP
MECANISMO DE DOENÇA

Shprintzen-Goldberg craniosynostosis syndrome

A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, intellectual disability, developmental delay and learning disabilities.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
235.4 TPM
Cerebelo
233.1 TPM
Artéria tibial
154.4 TPM
Aorta
150.9 TPM
Útero
107.2 TPM
OUTRAS DOENÇAS (2)
Shprintzen-Goldberg syndromechromosome 1p36 deletion syndrome
HGNC:10896UniProt:P12755
PRKCZProtein kinase C zeta typeRole in the phenotype ofRestrito
FUNÇÃO

Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAP

LOCALIZAÇÃO

CytoplasmEndosomeCell junctionMembrane

VIAS BIOLÓGICAS (1)
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
98.5 TPM
Cerebelo
89.3 TPM
Brain Frontal Cortex BA9
45.3 TPM
Córtex cerebral
41.6 TPM
Testículo
36.3 TPM
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:9412UniProt:Q05513
SPENMsx2-interacting proteinRole in the phenotype ofAltamente restrito
FUNÇÃO

May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
RHOBTB1 GTPase cycle
MECANISMO DE DOENÇA

Radio-Tartaglia syndrome

An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, hypotonia, mild motor difficulties, impaired intellectual development, speech delay, craniofacial dysmorphism, and variable behavioral abnormalities.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
52.0 TPM
Cerebelo
47.1 TPM
Ovário
45.3 TPM
Aorta
43.2 TPM
Nervo tibial
43.2 TPM
OUTRAS DOENÇAS (2)
Radio-Tartaglia syndromechromosome 1p36 deletion syndrome
HGNC:17575UniProt:Q96T58
PRDM16Histone-lysine N-methyltransferase PRDM16Role in the phenotype ofAltamente restrito
FUNÇÃO

Transcription regulator that acts both as a histone methyltransferase or chromatin adapter, depending on the context (PubMed:12816872). In the cytoplasm, acts as a histone methyltransferase, which catalyzes monomethylation of 'Lys-9' of free histone H3 (H3K9me1) during translation (By similarity). Monomethylated histone H3 is then transported to the nucleus and incorporated into nucleosomes where SUV39H methyltransferases (SUV39H1 and SUV39H2) use it as a substrate to catalyze histone H3 'Lys-9'

LOCALIZAÇÃO

NucleusChromosomeCytoplasm

VIAS BIOLÓGICAS (1)
PKMTs methylate histone lysines
MECANISMO DE DOENÇA

Left ventricular non-compaction 8

A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC8 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
37.2 TPM
Artéria tibial
30.3 TPM
Artéria coronária
24.6 TPM
Nervo tibial
20.5 TPM
Tireoide
18.6 TPM
OUTRAS DOENÇAS (4)
left ventricular noncompaction 8chromosome 1p36 deletion syndromefamilial isolated dilated cardiomyopathyleft ventricular noncompaction
HGNC:14000UniProt:Q9HAZ2
HSPG2Basement membrane-specific heparan sulfate proteoglycan core proteinRole in the phenotype ofRestrito
FUNÇÃO

Integral component of basement membranes. Component of the glomerular basement membrane (GBM), responsible for the fixed negative electrostatic membrane charge, and which provides a barrier which is both size- and charge-selective. It serves as an attachment substrate for cells. Plays essential roles in vascularization. Critical for normal heart development and for regulating the vascular response to injury. Also required for avascular cartilage development (PubMed:12435733, PubMed:15591058, Pub

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membraneSecreted

VIAS BIOLÓGICAS (1)
Degradation of the extracellular matrix
MECANISMO DE DOENÇA

Schwartz-Jampel syndrome

Rare autosomal recessive disorder characterized by permanent myotonia (prolonged failure of muscle relaxation) and skeletal dysplasia, resulting in reduced stature, kyphoscoliosis, bowing of the diaphyses and irregular epiphyses.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
280.8 TPM
Aorta
227.2 TPM
Nervo tibial
194.7 TPM
Artéria coronária
170.4 TPM
Cólon sigmoide
167.3 TPM
OUTRAS DOENÇAS (4)
Schwartz-Jampel syndrome type 1Silverman-Handmaker type dyssegmental dysplasiachromosome 1p36 deletion syndromeSchwartz-Jampel syndrome
HGNC:5273UniProt:P98160
KCNAB2Voltage-gated potassium channel subunit beta-2Role in the phenotype ofTolerante
FUNÇÃO

Regulatory subunit of the voltage-gated potassium (Kv) Shaker channels composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits (PubMed:11825900, PubMed:7649300). The beta-2/KCNAB2 cytoplasmic subunit promotes potassium channel closure via a mechanism that does not involve physical obstruction of the channel pore (PubMed:11825900, PubMed:7649300). Promotes the inactivation of Kv1.4/KCNA4 and Kv1.5/KCNA5 alpha subunit-containing channels (PubMed:11825900, P

LOCALIZAÇÃO

CytoplasmMembraneCell membraneCell projection, axonSynapse, synaptosomeCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Neutrophil degranulation
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
133.7 TPM
Córtex cerebral
133.6 TPM
Brain Anterior cingulate cortex BA24
102.4 TPM
Linfócitos
69.8 TPM
Hipocampo
69.5 TPM
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:6229UniProt:Q13303
MMP23BMatrix metalloproteinase-23Role in the phenotype ofModerado
FUNÇÃO

Protease. May regulate the surface expression of some potassium channels by retaining them in the endoplasmic reticulum (By similarity)

LOCALIZAÇÃO

Endoplasmic reticulum membraneMembrane

EXPRESSÃO TECIDUAL(Tecido-específico)
Ovário
6.4 TPM
Aorta
5.0 TPM
Artéria coronária
4.3 TPM
Pulmão
2.7 TPM
Útero
2.4 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:7171UniProt:O75900
PDPNPodoplaninRole in the phenotype ofTolerante
FUNÇÃO

Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation (PubMed:14522983, PubMed:15231832, PubMed:17222411, PubMed:17616532, PubMed:18215137). Interaction with CD9, on the contrary, attenuates platelet aggregation induced by PDPN (PubMed:18541721). Through MSN or EZR interaction promote

LOCALIZAÇÃO

MembraneCell projection, lamellipodium membraneCell projection, filopodium membraneCell projection, microvillus membraneCell projection, ruffle membraneMembrane raftApical cell membraneBasolateral cell membraneCell projection, invadopodiumCytoplasm, cytosol

VIAS BIOLÓGICAS (2)
GPVI-mediated activation cascadeSpecification of primordial germ cells
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
56.7 TPM
Adipose Visceral Omentum
50.5 TPM
Cervix Endocervix
49.0 TPM
Fallopian Tube
42.0 TPM
Ovário
40.0 TPM
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:29602UniProt:Q86YL7
REREArginine-glutamic acid dipeptide repeats proteinRole in the phenotype ofAltamente restrito
FUNÇÃO

Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death

LOCALIZAÇÃO

Nucleus

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
142.5 TPM
Cervix Endocervix
117.4 TPM
Cervix Ectocervix
92.9 TPM
Artéria tibial
92.2 TPM
Esôfago - Muscular
87.9 TPM
OUTRAS DOENÇAS (2)
neurodevelopmental disorder with or without anomalies of the brain, eye, or heartchromosome 1p36 deletion syndrome
HGNC:9965UniProt:Q9P2R6
UBE4BUbiquitin conjugation factor E4 BRole in the phenotype ofAltamente restrito
FUNÇÃO

Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases (By similarity). May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase (By similarity). May regulate myosin assembly in striated muscles together with STUB1 and VCP/p97 by targeting myosin chaperone UNC45B for proteasomal degradation (PubMed:17369820)

LOCALIZAÇÃO

CytoplasmNucleus

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
45.5 TPM
Cerebelo
41.3 TPM
Útero
36.7 TPM
Cólon sigmoide
35.6 TPM
Skin Sun Exposed Lower leg
34.3 TPM
OUTRAS DOENÇAS (1)
chromosome 1p36 deletion syndrome
HGNC:12500UniProt:O95155
GABRDGamma-aminobutyric acid receptor subunit deltaRole in the phenotype ofTolerante
FUNÇÃO

Delta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:35355020). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:35355020). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 5

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
538.4 TPM
Cerebelo
517.0 TPM
Brain Frontal Cortex BA9
104.9 TPM
Córtex cerebral
95.3 TPM
Brain Nucleus accumbens basal ganglia
54.4 TPM
OUTRAS DOENÇAS (4)
chromosome 1p36 deletion syndromegeneralized epilepsy with febrile seizures plusjuvenile myoclonic epilepsyepilepsy, idiopathic generalized, susceptibility to, 10
HGNC:4084UniProt:O14764

Variantes genéticas (ClinVar)

453 variantes patogênicas registradas no ClinVar.

🧬 LUZP1: NC_000001.10:g.(?_23395012)_(24673151_?)del ()
🧬 LUZP1: GRCh38/hg38 1p36.33-35.1(chr1:99125-34026935)x3 ()
🧬 LUZP1: GRCh37/hg19 1p36.13-36.12(chr1:16785250-23491592)x1 ()
🧬 LUZP1: GRCh37/hg19 1p36.33-q44(chr1:849467-249224684) ()
🧬 LUZP1: GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 15 variantes classificadas pelo ClinVar.

14
1
Patogênica (93.3%)
VUS (6.7%)
VARIANTES MAIS SIGNIFICATIVAS
ACOT7: GRCh37/hg19 1p36.33-36.31(chr1:1957148-6553454) [Pathogenic]
ACAP3: GRCh37/hg19 1p36.33-36.32(chr1:1-2580976)x1 [Pathogenic]
CASP9: NC_000001.10:g.4481271_20530242del [Pathogenic]
ACAP3: GRCh37/hg19 1p36.33-36.22(chr1:849466-10258804) [Pathogenic]
ACAP3: GRCh37/hg19 1p36.33-36.32(chr1:849466-4183006) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de deleção 1p36

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

2 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
78 papers (10 anos)
#1

First Detection of 1p36 Deletion by Whole-Exome Sequencing in a Tunisian Patient.

Birth defects research2026 Jan

We reported a rare case of 1p36 deletion syndrome diagnosed using whole-exome sequencing (WES) in a Tunisian neonate, and to highlight the utility of WES in detecting structural variants, particularly in resource-limited settings. Clinical and genetic investigations were conducted on a female neonate presenting with a severe polymalformative syndrome. WES was performed to detect potential genetic abnormalities, followed by validation through fluorescence in situ hybridization (FISH). Variant annotation and classification were done in accordance with ACMG guidelines. WES identified a heterozygous interstitial deletion in the 1p36 region, spanning 11.64 Mb and affecting 155 coding genes, including key genes such as MMP23B, GABRD, SKI, PRDM16, KCNAB2, RERE, UBE4B, and CASZ1. The deletion was classified as pathogenic, and FISH analysis confirmed its presence. Clinically, the patient exhibited intrauterine growth restriction, neonatal epilepsy, craniofacial dysmorphia, congenital heart defect, and agenesis of the corpus callosum. This is the first reported case in Tunisia of a 1p36 deletion identified via short-read WES. The findings support the expanding role of WES in structural variant detection and underscore its diagnostic value, especially in settings with limited access to chromosomal microarray or genome sequencing technologies.

#2

Two Cases of SPEN Haploinsufficiency Presenting with Dystonia: Expanding the Genotype and Phenotype.

Movement disorders clinical practice2026 Jan 12
#3

Dental Anomalies in 1p36 Deletion Syndrome: A Case Report.

Cureus2025 Nov

This report describes a nine-year, five-month-old Saudi girl with 1p36 deletion syndrome (1p36DS) referred for dental evaluation due to esthetic concerns. Clinical and radiographic assessment revealed multiple carious lesions, poor oral hygiene, dens invaginatus in maxillary incisors, infraocclusion of a primary molar, and, notably, agenesis of all primary and permanent canines except for one retained mandibular primary canine. Additionally, two supernumerary maxillary incisors (mesiodens) were identified, causing severe rotation of adjacent teeth, a combination of dental anomalies not previously documented in 1p36DS. A comprehensive treatment plan was executed, encompassing preventive measures, restorative care, surgical extraction of mesiodens, and interceptive orthodontic alignment using a 2×4 fixed appliance and transpalatal arch. These interventions led to improved esthetics, dental function, and psychosocial confidence. The management of 1p36DS patients requires a multidisciplinary approach due to the conjunction of craniofacial and systemic anomalies. Pediatric dentists play a crucial role in early detection, preventive care, and timely interventions, all of which contribute to enhanced function and quality of life. Routine panoramic imaging and vigilance for atypical dental patterns are critical for guiding genetic referrals and comprehensive care. This case broadens the known phenotypic spectrum of 1p36DS by documenting a novel dental presentation involving concurrent agenesis of both primary and permanent canines with supernumerary maxillary incisors. Early recognition of such anomalies enables timely diagnosis, personalized management, and multidisciplinary collaboration, emphasizing the vital role of pediatric dentists in the holistic care of patients with rare chromosomal disorders.

#4

Prenatally diagnosed chromosome 1p36 deletions: a retrospective case series, literature review, and genotype-phenotype correlations.

BMC medical genomics2025 Dec 01

Chromosome 1p36 deletion syndrome is the most common terminal autosomal deletion disorder. While postnatal features are well-defined, prenatal characterization remains less comprehensive. This study aims to delineate the prenatal sonographic and genetic spectrum of this syndrome and explore genotype-phenotype correlations. A retrospective analysis was conducted on 21 consecutive prenatally diagnosed cases of 1p36 deletion (2017–2025) from a single tertiary center. Data on maternal demographics, ultrasound findings, genetic results, inheritance patterns, and pregnancy outcomes were collected. A pooled analysis included 10 isolated cases (with complete ultrasound data) from our cohort and 33 previously reported cases. The cohort demonstrated a strong female predominance (71.4%, 15/21). Fifteen (71.4%) involved isolated 1p36 deletions, while six (28.6%) exhibited additional chromosomal aberrations. Pooled analysis of 43 prenatally diagnosed isolated cases (10 current and 33 published) revealed brain anomalies to be the most common prenatal feature (58.1%, 25/43), with ventriculomegaly (37.2%, 16/43), corpus callosum hypoplasia (9.3%, 4/43), and choroid plexus cysts (9.3%, 4/43) being the most frequent subtypes. Cardiac defects were observed in 39.5% (17/43) of cases, predominantly atrial/ventricular septal defects (ASD/VSD, 23.3%, 10/43) and Ebstein anomaly (11.6%, 5/43). Other frequently observed features included increased nuchal translucency (16.3%, 7/43) and single umbilical artery (14%, 6/43). Parental genetic analysis demonstrated de novo deletions in 80.0% (12/15) of cases, while 20.0% (3/15) were inherited from phenotypically normal parents. Congenital brain anomalies (particularly ventriculomegaly) and cardiac defects are hallmark prenatal features of isolated 1p36 deletion syndrome. Our findings underscore the role of key genes (RERE, SPEN, PRDM16, MMP23B) in shaping the phenotype and highlight the importance of parental genetic testing in counseling, given the potential for inherited variants with variable expressivity.

#5

Ultrasound Phenotype, Genetic Analysis, and Pregnancy Outcomes of Fetuses With 1p36 Deletion Syndrome.

Molecular genetics &amp; genomic medicine2025 May

The intrauterine ultrasound phenotype, genotype, pregnancy outcome, and neonatal prognosis of fetuses with 1p36 deletion syndrome were retrospectively analyzed, as previous reports are limited. Pregnant women (25,000) who underwent interventional prenatal diagnosis between December 2016 and March 2024 were selected. Fetal villus tissue, amniotic fluid, or umbilical cord blood were extracted for single nucleotide polymorphism array (SNP-array) detection under ultrasound guidance. Thirteen fetuses had 1p36 deletions involving fragments that were 0.46-22.5 Mb. Six and seven fetuses had large and small copy number variation (CNV) fragment deletions in the 1p36 region, respectively. Two fetuses had normal ultrasound phenotypes, three underwent early spontaneous abortion, one had isolated ventricular septal defect, one had isolated mild ventriculomegaly, two had mild ventriculomegaly associated with increased renal echogenicity, one had mild ventriculomegaly associated with ventricular septal defect, one had severe ventriculomegaly associated with ventricular septal defect and fetal growth restriction, one had tricuspid valve dysplasia, and one had nasal bone dysplasia. Three 1p36 deletions were de novo, and one was paternally inherited. There were three cases of early spontaneous abortion, seven terminations, and three routine postnatal follow-ups. High-resolution SNP-arrays are suitable for the prenatal diagnosis of 1p36 deletion syndrome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC71 artigos no totalmostrando 63

2026

First Detection of 1p36 Deletion by Whole-Exome Sequencing in a Tunisian Patient.

Birth defects research
2026

Two Cases of SPEN Haploinsufficiency Presenting with Dystonia: Expanding the Genotype and Phenotype.

Movement disorders clinical practice
2025

Dental Anomalies in 1p36 Deletion Syndrome: A Case Report.

Cureus
2025

Prenatally diagnosed chromosome 1p36 deletions: a retrospective case series, literature review, and genotype-phenotype correlations.

BMC medical genomics
2025

Ultrasound Phenotype, Genetic Analysis, and Pregnancy Outcomes of Fetuses With 1p36 Deletion Syndrome.

Molecular genetics &amp; genomic medicine
2025

Anesthesia management for dental procedures in a patient with 1p36 deletion syndrome: a case report.

Journal of dental anesthesia and pain medicine
2024

First-trimester application of expanded non-invasive prenatal testing in the genetic investigation of fetal 1p36 deletion syndrome associated with a familial unbalanced reciprocal translocation of 46,XX,der(1)t(1;2) (p36.2;q37.3)dmat.

Taiwanese journal of obstetrics &amp; gynecology
2025

DNA methylation dysregulation patterns in the 1p36 region instability.

Journal of applied genetics
2024

Breaking new ground: Exploring de novo chromosomal rearrangements in 1p36 microdeletion.

International journal of health sciences
2024

[Prenatal diagnosis of a fetus with 1p36 deletion syndrome and 3p26.3p25.2 duplication].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

PRDM16 co-operates with LHX2 to shape the human brain.

Oxford open neuroscience
2024

[Analysis of genetic etiology in a patient with 1p36 deletion syndrome in conjunct with Snijders Blok-Campeau syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Genetic Analysis of 1p36 Deletions for Six Aborted Fetuses.

Alternative therapies in health and medicine
2024

Congenital diaphragmatic hernia in patient with 1p36 deletion.

Clinical case reports
2024

Noninsulinoma Pancreatogenous Hypoglycemia Syndrome in a Patient With 1p36 Deletion Syndrome.

JCEM case reports
2023

Deletion in 1p36.33-p36.32 is associated with pancytopenia: a case report.

BMC medical genomics
2023

A Rare Case of an Infant With 1p36 Deletion Syndrome Presenting With Systolic Heart Failure Secondary to Severe Dilated Cardiomyopathy.

Cureus
2023

PRDM16 Deletion Is Associated With Sex-dependent Cardiomyopathy and Cardiac Mortality: A Translational, Multi-Institutional Cohort Study.

Circulation. Genomic and precision medicine
2023

1p36 deletion syndrome: Review and mapping with further characterization of the phenotype, a new cohort of 86 patients.

American journal of medical genetics. Part A
2022

Outcome of Vertical Expandable Prosthetic Titanium Rib (VEPTR) Instrumentation in Scoliosis Associated With 1p36 Deletion Syndrome: A Case Report.

Cureus
2022

Abatacept as an alternative therapy for the treatment of drug-intolerant lupus nephritis: A case of underlying monosomy 1p36 deletion syndrome.

Clinical nephrology
2024

Prenatal diagnosis of pure 1p36 terminal deletion by chromosome microarry analysis - clinical report of 3 new cases and review of the literature.

Ginekologia polska
2022

Monosomy 1p36: Report of a cohort of 13 Asian Indian patients.

American journal of medical genetics. Part A
2021

Psychiatric Comorbidities in 1p36 Deletion Syndrome and Their Treatment-A Case Report.

International journal of environmental research and public health
2021

1p36 Deletion Syndrome and the Aorta: A Report of Three New Patients and a Literature Review.

Journal of cardiovascular development and disease
2021

Novel Point Mutation of EBSS Gene Coexisted with 1p36 Deletion.

Annals of dermatology
2021

Noncongenital juvenile-onset bilateral lamellar cataract in 1p36 deletion syndrome.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2021

The Neuropathology of 1p36 Deletion Syndrome: An Autopsy Case Series.

Journal of neuropathology and experimental neurology
2021

1p36 Deletion Syndrome and Left Ventricular Non-compaction Cardiomyopathy-Two Cases Report.

Frontiers in pediatrics
2021

RERE deficiency contributes to the development of orofacial clefts in humans and mice.

Human molecular genetics
2020

1p36 deletion syndrome: first case report in Morocco detected by fluorescence in situ hybridization.

The Pan African medical journal
2021

SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females.

American journal of human genetics
2020

A rare cardiac phenotype of dextrocardia observed in a fetus with 1p36 deletion syndrome and a balanced translocation: a prenatal case report.

Molecular cytogenetics
2020

Non-invasive prenatal testing (NIPT) by low coverage genomic sequencing: Detection limits of screened chromosomal microdeletions.

PloS one
2020

Dental anomalies as a possible clue of 1p36 deletion syndrome due to germline mosaicism: a case report.

BMC pediatrics
2020

A new 1p36.13-1p36.12 microdeletion syndrome characterized by learning disability, behavioral abnormalities, and ptosis.

Clinical genetics
2020

Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma.

Cell reports
2021

Prenatal detection of 1p36 deletion syndrome: ultrasound findings and microarray testing results.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2019

Perinatal distress in 1p36 deletion syndrome can mimic hypoxic ischemic encephalopathy.

American journal of medical genetics. Part A
2019

Prenatal findings in 1p36 deletion syndrome: New cases and a literature review.

Prenatal diagnosis
2018

Rer1-mediated quality control system is required for neural stem cell maintenance during cerebral cortex development.

PLoS genetics
2018

Electroclinical features of epilepsy monosomy 1p36 syndrome and their implications.

Acta neurologica Scandinavica
2018

Identification of a New Candidate Locus for Ebstein Anomaly in 1p36.2.

Molecular syndromology
2018

Cutis laxa in a patient with 1p36 deletion syndrome.

The Journal of dermatology
2018

1p deletion syndrome: A prenatal diagnosis characterized by an abnormal 1st trimester combined screening test, yet a normal NIPT result.

Taiwanese journal of obstetrics &amp; gynecology
2018

Genotype-phenotype correlations in individuals with pathogenic RERE variants.

Human mutation
2018

Electroclinical features of epilepsy associated with 1p36 deletion syndrome: A review.

Epilepsy research
2017

[Prenatal diagnosis of two fetuses with chromosome 1p36 deletion syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2018

Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.

Pediatric diabetes
2016

1p36 deletion syndrome confirmed by fluorescence in situ hybridization and array-comparative genomic hybridization analysis.

Korean journal of pediatrics
2016

[An updated review of 1p36 deletion (monosomy) syndrome].

Revista chilena de pediatria
2017

Abdominal paraganglioma in a young woman with 1p36 deletion syndrome.

American journal of medical genetics. Part A
2017

Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome.

Journal of applied genetics
2016

The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Immunity
2016

Is 1p36 deletion associated with anterior body wall defects?

American journal of medical genetics. Part A
2016

De Novo Mutations of RERE Cause a Genetic Syndrome with Features that Overlap Those Associated with Proximal 1p36 Deletions.

American journal of human genetics
2016

Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2016

Mini-Review: Monosomy 1p36 syndrome: reviewing the correlation between deletion sizes and phenotypes.

Genetics and molecular research : GMR
2016

Identification of 1p36 deletion syndrome in patients with facial dysmorphism and developmental delay.

Korean journal of pediatrics
2015

1p36 deletion syndrome: an update.

The application of clinical genetics
2015

Left Ventricular Non-compaction: Is It Genetic?

Pediatric cardiology
2015

Are Angelman and Prader-Willi syndromes more similar than we thought? Food-related behavior problems in Angelman, Cornelia de Lange, fragile X, Prader-Willi and 1p36 deletion syndromes.

American journal of medical genetics. Part A
2014

Left ventricular noncompaction cardiomyopathy: adult association with 1p36 deletion syndrome.

Methodist DeBakey cardiovascular journal
Ver todos os 71 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de deleção 1p36.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de deleção 1p36

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. First Detection of 1p36 Deletion by Whole-Exome Sequencing in a Tunisian Patient.
    Birth defects research· 2026· PMID 41556146mais citado
  2. Two Cases of SPEN Haploinsufficiency Presenting with Dystonia: Expanding the Genotype and Phenotype.
    Movement disorders clinical practice· 2026· PMID 41525714mais citado
  3. Dental Anomalies in 1p36 Deletion Syndrome: A Case Report.
    Cureus· 2025· PMID 41393688mais citado
  4. Prenatally diagnosed chromosome 1p36 deletions: a retrospective case series, literature review, and genotype-phenotype correlations.
    BMC medical genomics· 2025· PMID 41327254mais citado
  5. Ultrasound Phenotype, Genetic Analysis, and Pregnancy Outcomes of Fetuses With 1p36 Deletion Syndrome.
    Molecular genetics &amp; genomic medicine· 2025· PMID 40285432mais citado
  6. An enhanced transformer model for detecting 1p36 deletion syndrome.
    Mol Genet Genomics· 2026· PMID 41917487recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1606(Orphanet)
  2. OMIM OMIM:607872(OMIM)
  3. MONDO:0011929(MONDO)
  4. GARD:6082(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q3297103(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de deleção 1p36
Compêndio · Raras BR

Síndrome de deleção 1p36

ORPHA:1606 · MONDO:0011929
Prevalência
1-5 / 10 000
Herança
Multigenic/multifactorial, Not applicable
CID-10
Q93.5 · Outras deleções parciais de cromossomo
CID-11
Ensaios
1 ativos
Início
Antenatal, Neonatal
Prevalência
15.0 (United States)
MedGen
UMLS
C1842870
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades